{"id":286,"date":"2014-06-10T14:18:32","date_gmt":"2014-06-10T18:18:32","guid":{"rendered":"http:\/\/www.gqr-lmc-nmp.ca\/?p=286"},"modified":"2014-06-10T14:22:31","modified_gmt":"2014-06-10T18:22:31","slug":"partenariat-entre-pfizer-et-avillion-afin-de-co-developper-bosulif-bosutinib-comme-traitement-de-premiere-ligne-en-lmc","status":"publish","type":"post","link":"https:\/\/www.gqr-lmc-nmp.ca\/system\/2014\/06\/10\/partenariat-entre-pfizer-et-avillion-afin-de-co-developper-bosulif-bosutinib-comme-traitement-de-premiere-ligne-en-lmc\/","title":{"rendered":"Partenariat entre Pfizer et Avillion afin de co-d\u00e9velopper BOSULIF\u00ae (bosutinib) comme traitement de premi\u00e8re ligne en LMC."},"content":{"rendered":"<p><a href=\"https:\/\/www.gqr-lmc-nmp.ca\/system\/system\/wp-content\/uploads\/2014\/06\/avillion-group-partners-with-pfizer-to-co-develop-bosulif-bosutinib-as-first-line-treatment-for-patients-with-chronic-myelogenous-leukemia-.pdf\">Avillion Group Partners with Pfizer to Co-develop BOSULIF\u00ae (bosutinib) as First-Line Treatment for Patients with CML<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Avillion Group Partners with Pfizer to Co-develop BOSULIF\u00ae (bosutinib) as First-Line Treatment for Patients with CML<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/posts\/286"}],"collection":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/comments?post=286"}],"version-history":[{"count":1,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/posts\/286\/revisions"}],"predecessor-version":[{"id":289,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/posts\/286\/revisions\/289"}],"wp:attachment":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/media?parent=286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/categories?post=286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/tags?post=286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}